Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux.

PubWeight™: 1.25‹?› | Rank: Top 10%

🔗 View Article (PMC 3833931)

Published in J Natl Cancer Inst on October 29, 2013

Authors

Weronica E Ek1, David M Levine, Mauro D'Amato, Nancy L Pedersen, Patrik K E Magnusson, Francesca Bresso, Lynn E Onstad, Peter T Schmidt, Hans Törnblom, Helena Nordenstedt, Yvonne Romero, Mayo Clinic Esophageal Adenocarcinoma and Barrett’s Esophagus Registry Consortium, Wong-Ho Chow, Liam J Murray, Marilie D Gammon, Geoffrey Liu, Leslie Bernstein, Alan G Casson, Harvey A Risch, Nicholas J Shaheen, Nigel C Bird, Brian J Reid, Douglas A Corley, Laura J Hardie, Weimin Ye, Anna H Wu, Marco Zucchelli, Tim D Spector, Pirro Hysi, Thomas L Vaughan, David C Whiteman, Stuart MacGregor, BEACON study investigators

Author Affiliations

1: Affiliations of authors: Statistical Genetics (WEE, SM) and Cancer Control Group (DCW), QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia (WEE, SM); Department of Biostatistics, University of Washington, Seattle, WA (DML); Department of Biosciences and Nutrition (MD, FB, MZ) Department of Medical Epidemiology and Biostatistics (NLP, PKEM), Unit of Upper Gastrointestinal Research, Department of Molecular Medicine and Surgery (HN) , and Department of Medical Epidemiology and Biostatistics (WY) , Karolinska Institutet, Stockholm, Sweden; Gastrocentrum Medicin, Karolinska University Hospital, Stockholm, Sweden (FB, PTS); Division of Public Health Sciences (LEO, TLV) and Division of Human Biology (BJR), Fred Hutchinson Cancer Research Center, Seattle, WA; Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden (HT); Division of Gastroenterology & Hepatology (YR), Department of Otolaryngology (YR), and GI Outcomes Unit (YR), Mayo Clinic, Rochester, MN; Department of Epidemiology, MD Anderson Cancer Center, Houston, TX (W-HC); Centre for Public Health, Queen's University, Belfast, Ireland (LJM); Department of Epidemiology, School of Public Health (MDG) and Division of Gastroenterology and Hepatology, UNC School of Medicine (NJS) , University of North Carolina, Chapel Hill, NC (MDG); Pharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, ON, Canada (GL); Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, CA (LB); Department of Surgery, University of Saskatchewan, Saskatoon, SK, Canada (AGC); Yale School of Public Health, New Haven, CT (HAR); Department of Oncology, The Medical School, University of Sheffield, Sheffield, UK (NCB); Division of Research and Oakland Medical Center, Kaiser Permanente, Oakland, CA (DAC); Division of Epidemiology, University of Leeds, Leeds, UK (LJH); Department of Preventive Medicine,

Articles citing this

ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol (2015) 3.22

Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol (2016) 1.40

Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology (2014) 1.08

Esophageal cancer: Risk factors, screening and endoscopic treatment in Western and Eastern countries. World J Gastroenterol (2015) 1.07

Estimating the heritability of colorectal cancer. Hum Mol Genet (2014) 1.02

Chronic gastroesophageal reflux disease shares genetic background with esophageal adenocarcinoma and Barrett's esophagus. Hum Mol Genet (2015) 1.01

Biomarkers for dysplastic Barrett's: ready for prime time? World J Surg (2015) 0.89

Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol (2015) 0.88

Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis (2014) 0.87

Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's Esophagus. Cancer Prev Res (Phila) (2015) 0.87

MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One (2015) 0.84

Association of promoter methylation of RUNX3 gene with the development of esophageal cancer: a meta analysis. PLoS One (2014) 0.82

The Role of Gastroesophageal Reflux and Other Factors during Progression to Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev (2015) 0.82

Cigarette smoke mediates epigenetic repression of miR-217 during esophageal adenocarcinogenesis. Oncogene (2015) 0.81

Genetic Insights in Barrett's Esophagus and Esophageal Adenocarcinoma. Gastroenterology (2015) 0.81

Reevaluation of SNP heritability in complex human traits. Nat Genet (2017) 0.78

A Newly Identified Susceptibility Locus near FOXP1 Modifies the Association of Gastroesophageal Reflux with Barrett's Esophagus. Cancer Epidemiol Biomarkers Prev (2015) 0.77

Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer (2015) 0.76

Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium. PLoS One (2015) 0.76

Pleiotropic Analysis of Cancer Risk Loci on Esophageal Adenocarcinoma Risk. Cancer Epidemiol Biomarkers Prev (2015) 0.76

Risk Factors for Barrett's Oesophagus. Gastrointest Tumors (2016) 0.75

Association of genetic polymorphisms with laryngeal carcinoma prognosis in a Chinese population. Oncotarget (2016) 0.75

Etiology and Prevention of Esophageal Cancer. Gastrointest Tumors (2016) 0.75

Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus. Gastroenterol Clin North Am (2015) 0.75

Linkage and related analyses of Barrett's esophagus and its associated adenocarcinomas. Mol Genet Genomic Med (2016) 0.75

Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm. Cancer Epidemiol Biomarkers Prev (2016) 0.75

Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut (2016) 0.75

Genetic susceptibility to Barrett's oesophagus: Lessons from early studies. United European Gastroenterol J (2015) 0.75

Articles cited by this

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature (2009) 33.26

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med (2000) 25.49

GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet (2010) 20.73

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol (2006) 20.28

Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet (2011) 8.95

Incidence of adenocarcinoma among patients with Barrett's esophagus. N Engl J Med (2011) 8.62

Prediction of individual genetic risk to disease from genome-wide association studies. Genome Res (2007) 8.48

Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut (2005) 7.35

Rare and common variants: twenty arguments. Nat Rev Genet (2012) 6.67

Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Res (2003) 6.43

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology (2005) 5.77

Estimation of pleiotropy between complex diseases using single-nucleotide polymorphism-derived genomic relationships and restricted maximum likelihood. Bioinformatics (2012) 3.97

Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94

Progress and promise of genome-wide association studies for human complex trait genetics. Genetics (2010) 3.81

The UK Adult Twin Registry (TwinsUK). Twin Res Hum Genet (2006) 3.72

Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am (2002) 3.69

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer (2010) 3.27

Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol (2007) 3.18

Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst (2003) 3.07

Evaluating the heritability explained by known susceptibility variants: a survey of ten complex diseases. Genet Epidemiol (2011) 2.78

Polygenic modeling with bayesian sparse linear mixed models. PLoS Genet (2013) 2.59

Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol (2001) 2.56

A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol (2007) 2.31

Central adiposity and risk of Barrett's esophagus. Gastroenterology (2007) 2.20

Heritability and genetic correlations explained by common SNPs for metabolic syndrome traits. PLoS Genet (2012) 2.11

p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res (2001) 2.06

Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet (2010) 2.04

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89

Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol (2005) 1.85

Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut (2003) 1.85

Gastroesophageal reflux disease in monozygotic and dizygotic twins. Gastroenterology (2002) 1.76

Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut (2002) 1.57

Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet (2012) 1.52

Lifestyle related risk factors in the aetiology of gastro-oesophageal reflux. Gut (2004) 1.47

Risk factors of gastroesophageal reflux disease: methodology and first epidemiological results of the ProGERD study. J Clin Epidemiol (2004) 1.47

Familial aggregation of gastroesophageal reflux in patients with Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology (1997) 1.46

Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females. Gut (2008) 1.41

Continuing rising trend in oesophageal adenocarcinoma. Int J Cancer (2002) 1.37

Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology (2012) 1.28

Identification of Barrett's esophagus in relatives by endoscopic screening. Am J Gastroenterol (2004) 1.26

Population attributable fractions of adenocarcinoma of the esophagus and gastroesophageal junction. Am J Epidemiol (2011) 0.99

Carcinoma arising in familial Barrett's esophagus. Am J Gastroenterol (1996) 0.99

Barrett's esophagus and its progression to adenocarcinoma. J Natl Compr Canc Netw (2006) 0.93

A family history of Barrett's oesophagus: another risk factor? Scand J Gastroenterol (2005) 0.92

Complex diseases in gastroenterology and hepatology: GERD, Barrett's, and esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2005) 0.92

The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterol Motil (2011) 0.88

High risk of malignancy in familial Barrett's esophagus: presentation of one family. J Clin Gastroenterol (2008) 0.85

Articles by these authors

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38

Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13

A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature (2008) 16.10

Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A (2005) 15.46

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat Genet (2008) 12.32

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

Ceritinib in ALK-rearranged non-small-cell lung cancer. N Engl J Med (2014) 9.94

Cancer as an evolutionary and ecological process. Nat Rev Cancer (2006) 9.33

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet (2011) 7.98

Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet (2012) 7.59

Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44

Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med (2013) 7.30

Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology (2012) 7.15

A common genetic risk factor for colorectal and prostate cancer. Nat Genet (2007) 7.11

Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97

Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med (2011) 6.79

Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet (2006) 6.71

Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry (2006) 6.68

The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med (2004) 6.55

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol (2005) 6.44

Epidemiologic evaluation of measurement data in the presence of detection limits. Environ Health Perspect (2004) 6.43

Heritability of adult body height: a comparative study of twin cohorts in eight countries. Twin Res (2003) 6.43

A genome-wide meta-analysis identifies 22 loci associated with eight hematological parameters in the HaemGen consortium. Nat Genet (2009) 6.31

Air pollution and lung cancer incidence in 17 European cohorts: prospective analyses from the European Study of Cohorts for Air Pollution Effects (ESCAPE). Lancet Oncol (2013) 6.12

Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst (2008) 6.00

American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93

Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70

Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet (2011) 5.58

Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles. Am J Hum Genet (2008) 5.53

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14

A genome-wide perspective of genetic variation in human metabolism. Nat Genet (2009) 5.00

Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet (2009) 4.97

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89

Oral contraceptives and the risk of breast cancer. N Engl J Med (2002) 4.85

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

GWAS of 126,559 individuals identifies genetic variants associated with educational attainment. Science (2013) 4.71

Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA (2013) 4.67

Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet (2010) 4.65

Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med (2013) 4.64

A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15. Nat Genet (2007) 4.61

Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56

Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51

Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer (2009) 4.50

A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35

Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study. J Natl Cancer Inst (2011) 4.31

Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA (2004) 4.31

Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium. Nat Genet (2009) 4.28

Quality indicators for colonoscopy. Gastrointest Endosc (2014) 4.17

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

Epigenome-wide scans identify differentially methylated regions for age and age-related phenotypes in a healthy ageing population. PLoS Genet (2012) 4.05

Characterization of a common susceptibility locus for asthma-related traits. Science (2004) 4.05

Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res (2008) 4.02

Personality and major depression: a Swedish longitudinal, population-based twin study. Arch Gen Psychiatry (2006) 3.94

Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst (2007) 3.93

Identification of seven loci affecting mean telomere length and their association with disease. Nat Genet (2013) 3.87

A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86

New models for large prospective studies: is there a better way? Am J Epidemiol (2012) 3.85

Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet (2007) 3.84

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest Endosc (2010) 3.74

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Detectable clonal mosaicism from birth to old age and its relationship to cancer. Nat Genet (2012) 3.68

The association between physical activity in leisure time and leukocyte telomere length. Arch Intern Med (2008) 3.68

Effect of low doses of ionising radiation in infancy on cognitive function in adulthood: Swedish population based cohort study. BMJ (2004) 3.67

Leisure time spent sitting in relation to total mortality in a prospective cohort of US adults. Am J Epidemiol (2010) 3.64

Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: a meta-analysis of epidemiological studies. Breast Cancer Res (2006) 3.62

Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology (2003) 3.58

Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol (2009) 3.58

The Swedish Twin Registry in the third millennium: an update. Twin Res Hum Genet (2006) 3.58